MNOV News - Candlesense

MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference

(NASDAQ:MNOV) LA JOLLA, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the To...

Investor relations

11 days ago

MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial

LA JOLLA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exch...

How does MNOV's progress with MN‑166 compare to other ALS pipeline candidates in terms of trial design, funding and potential market impact? What are the expected timelines for data readout from the COMBAT‑ALS trial and how might that influence the share price volatility? How will the successful enrollment milestone affect MNOV's short‑term stock momentum and trading volume?

Clinical trials

19 days ago